<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35570238</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-0973</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Infection</Title><ISOAbbreviation>Infection</ISOAbbreviation></Journal><ArticleTitle>Respiratory muscle dysfunction in long-COVID patients.</ArticleTitle><Pagination><StartPage>1391</StartPage><EndPage>1397</EndPage><MedlinePgn>1391-1397</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s15010-022-01840-9</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Symptoms often persistent for more than 4 weeks after COVID-19-now commonly referred to as 'Long COVID'. Independent of initial disease severity or pathological pulmonary functions tests, fatigue, exertional intolerance and dyspnea are among the most common COVID-19 sequelae. We hypothesized that respiratory muscle dysfunction might be prevalent in persistently symptomatic patients after COVID-19 with self-reported exercise intolerance.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a small cross-sectional pilot study (n&#x2009;=&#x2009;67) of mild-to-moderate (nonhospitalized) and moderate-to-critical convalescent (formerly hospitalized) patients presenting to our outpatient clinic approx. 5&#xa0;months after acute infection, we measured neuroventilatory activity P<sub>0.1</sub>, inspiratory muscle strength (PI<sub>max</sub>) and total respiratory muscle strain (P<sub>0.1</sub>/PI<sub>max</sub>) in addition to standard pulmonary functions tests, capillary blood gas analysis, 6&#xa0;min walking tests and functional questionnaires.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Pathological P<sub>0.1</sub>/PI<sub>max</sub> was found in 88% of symptomatic patients. Mean PI<sub>max</sub> was reduced in hospitalized patients, but reduced PI<sub>max</sub> was also found in 65% of nonhospitalized patients. Mean P<sub>0.1</sub> was pathologically increased in both groups. Increased P<sub>0.1</sub> was associated with exercise-induced deoxygenation, impaired exercise tolerance, decreased activity and productivity and worse Post-COVID-19 functional status scale. Pathological changes in P<sub>0.1</sub>, PI<sub>max</sub> or P<sub>0.1</sub>/PI<sub>max</sub> were not associated with pre-existing conditions.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings point towards respiratory muscle dysfunction as a novel aspect of COVID-19 sequelae. Thus, we strongly advocate for systematic respiratory muscle testing during the diagnostic workup of persistently symptomatic, convalescent COVID-19 patients.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hennigs</LastName><ForeName>Jan K</ForeName><Initials>JK</Initials><Identifier Source="ORCID">0000-0002-7784-8267</Identifier><AffiliationInfo><Affiliation>Division of Pneumology, II. Department of Medicine, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. j.hennigs@uke.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huwe</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Pneumology, II. Department of Medicine, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hennigs</LastName><ForeName>Annette</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, I. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oqueka</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Pneumology, II. Department of Medicine, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simon</LastName><ForeName>Marcel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Pneumology, II. Department of Medicine, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harbaum</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Pneumology, II. Department of Medicine, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xf6;rbelin</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Pneumology, II. Department of Medicine, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmiedel</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, I. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulze Zur Wiesch</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, I. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Addo</LastName><ForeName>Marylyn M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, I. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, 20359, Hamburg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Infection Research (DZIF), Partner Site Hamburg-L&#xfc;beck-Borstel-Riems, 20359, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kluge</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klose</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Pneumology, II. Department of Medicine, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Infection</MedlineTA><NlmUniqueID>0365307</NlmUniqueID><ISSNLinking>0300-8126</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Infection. 2023 Apr;51(2):527-530. doi: 10.1007/s15010-022-01899-4</RefSource><PMID Version="1">35972679</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012132" MajorTopicYN="N">Respiratory Muscles</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">P0.1</Keyword><Keyword MajorTopicYN="N">P0.1/PImax</Keyword><Keyword MajorTopicYN="N">PImax</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>15</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35570238</ArticleId><ArticleId IdType="pmc">PMC9108020</ArticleId><ArticleId IdType="doi">10.1007/s15010-022-01840-9</ArticleId><ArticleId IdType="pii">10.1007/s15010-022-01840-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wichmann D, Sperhake JP, Lutgehetmann M, Steurer S, Edler C, Heinemann A, Heinrich F, Mushumba H, Kniep I, Schroder AS, et al. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann Intern Med. 2020;173:268&#x2013;277. doi: 10.7326/M20-2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-2003</ArticleId><ArticleId IdType="pmc">PMC7240772</ArticleId><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles VG, Lutgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, Chilla S, Heinemann A, Wanner N, Liu S, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020;383:590&#x2013;592. doi: 10.1056/NEJMc2011400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2011400</ArticleId><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, Pujol JC, Klaser K, Antonelli M, Canas LS, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennigs JK, Oqueka T, Harbaum L, Klose H. Organ-specific sequelae of COVID-19 in adults. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022;65:462&#x2013;470. doi: 10.1007/s00103-022-03513-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00103-022-03513-2</ArticleId><ArticleId IdType="pmc">PMC8925979</ArticleId><ArticleId IdType="pubmed">35294563</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam GY, Befus AD, Damant RW, Ferrara G, Fuhr DP, Stickland MK, Varughese RA, Wong EY, Smith MP. Exertional intolerance and dyspnea with preserved lung function: an emerging long COVID phenotype? Respir Res. 2021;22:222. doi: 10.1186/s12931-021-01814-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-021-01814-9</ArticleId><ArticleId IdType="pmc">PMC8343348</ArticleId><ArticleId IdType="pubmed">34362372</ArticleId></ArticleIdList></Reference><Reference><Citation>Laveneziana P, Albuquerque A, Aliverti A, Babb T, Barreiro E, Dres M, Dube BP, Fauroux B, Gea J, Guenette JA, et al. ERS statement on respiratory muscle testing at rest and during exercise. Eur Respir J. 2019 doi: 10.1183/13993003.01214-2018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01214-2018</ArticleId><ArticleId IdType="pubmed">30956204</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabitz HJ, Windisch W. Respiratory muscle testing: state of the art. Pneumologie. 2007;61:582&#x2013;587. doi: 10.1055/s-2007-980080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-980080</ArticleId><ArticleId IdType="pubmed">17659492</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon G, Barco S, Endres M, Geelhoed JJM, Knauss S, Rezek SA, Spruit MA, Vehreschild J, Siegerink B. The post-COVID-19 functional status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020 doi: 10.1183/13993003.01494-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Z, de Vries HJ, Vlaar APJ, van der Hoeven J, Boon RA, Heunks LMA, Ottenheijm CAC. Dutch C-DI: diaphragm pathology in critically ill patients with COVID-19 and postmortem findings from 3 medical centers. JAMA Intern Med. 2020 doi: 10.1001/jamainternmed.2020.6278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.6278</ArticleId><ArticleId IdType="pmc">PMC7670391</ArticleId><ArticleId IdType="pubmed">33196760</ArticleId></ArticleIdList></Reference><Reference><Citation>Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, Calverley PM, Gift AG, Harver A, Lareau SC, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185:435&#x2013;452. doi: 10.1164/rccm.201111-2042ST.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201111-2042ST</ArticleId><ArticleId IdType="pmc">PMC5448624</ArticleId><ArticleId IdType="pubmed">22336677</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>